Is molecular adsorbent recirculating system effective for all the liver failure patients?

Since its introduction in 1993, molecular adsorbent recirculating system (MARS) albumin dialysis has been a subject of research, with the hope of treating effectively patients with acute liver failure. The impact of MARS treatment on outcome as well as clinical and laboratory variables has been investigated widely in small non-randomised studies. However, larger studies with longer follow-up time are required to determine the true usefulness of MARS treatment in different liver failure aetiologies...

Read the whole article on

More from